{"DataElement":{"publicId":"7479648","version":"1","preferredName":"Primary Cellular Therapy Indication Reason","preferredDefinition":"An explanation of the primary indication for cellular therapy.","longName":"7479644v1.0:3158621v1.1","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7479644","version":"1","preferredName":"Primary Cellular Therapy Indication","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value._Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"7479642v1.0:2193066v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"7479642","version":"1","preferredName":"Primary Cellular Therapy","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value.:Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.","longName":"C25251:C70601","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cellular Therapy","conceptCode":"C70601","definition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B295BC78-089E-5886-E053-4EBD850AEE9C","latestVersionIndicator":"Yes","beginDate":"2020-10-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-26","modifiedBy":"ONEDATA","dateModified":"2020-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2193066","version":"1","preferredName":"Indication","preferredDefinition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"C41184","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EAA83722-8121-511A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-08","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B295BC78-08AC-5886-E053-4EBD850AEE9C","latestVersionIndicator":"Yes","beginDate":"2020-10-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-26","modifiedBy":"MALUMK","dateModified":"2021-01-28","changeDescription":"Released. 01/28/2021 KMM; Released. 01/28/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3158621","version":"1.1","preferredName":"Cellular Therapy Indication Reason","preferredDefinition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication)._An explanation of the cause of some phenomenon or action.","longName":"3158621v1.1","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Cardio and peripheral vascular disease","valueDescription":"Cardiovascular And Peripheral Vascular Disorder Disease or Disorder","ValueMeaning":{"publicId":"3158626","version":"1","preferredName":"Cardiovascular And Peripheral Vascular Disorder Disease or Disorder","longName":"3158626","preferredDefinition":"Cardiovascular; pertaining to the heart or blood vessels.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Any disorder affecting blood flow through the veins or arteries outside of the heart.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiovascular","conceptCode":"C25292","definition":"Pertaining to the heart or blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Peripheral Vascular Disorder","conceptCode":"C35136","definition":"Any disorder affecting blood flow through the veins or arteries outside of the heart.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94B8AE1D-5C6A-C169-E040-BB89AD435EB4","latestVersionIndicator":"Yes","beginDate":"2010-11-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A705C43-FB4B-F5BD-E050-BB89AD432FFF","beginDate":"2010-11-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-12-17","modifiedBy":"ONEDATA","dateModified":"2014-12-17","deletedIndicator":"No"},{"value":"Autoimmune disease","valueDescription":"Autoimmune Disease","ValueMeaning":{"publicId":"2585785","version":"1","preferredName":"Autoimmune Disease","longName":"2585785","preferredDefinition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis). \r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Disease","conceptCode":"C2889","definition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26B7A966-8345-0BC2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-10","modifiedBy":"TAYLORT","dateModified":"2020-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A705C43-FB55-F5BD-E050-BB89AD432FFF","beginDate":"2010-11-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-12-17","modifiedBy":"ONEDATA","dateModified":"2014-12-17","deletedIndicator":"No"},{"value":"Other disease","valueDescription":"Other Disease or Disorder","ValueMeaning":{"publicId":"3158622","version":"1","preferredName":"Other Disease or Disorder","longName":"3158622","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94B8AE1D-5BF8-C169-E040-BB89AD435EB4","latestVersionIndicator":"Yes","beginDate":"2010-11-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A705C43-FC1C-F5BD-E050-BB89AD432FFF","beginDate":"2010-11-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-12-17","modifiedBy":"ONEDATA","dateModified":"2014-12-17","deletedIndicator":"No"},{"value":"Musculoskeletal disease","valueDescription":"Musculoskeletal Disease or Disorder","ValueMeaning":{"publicId":"3158624","version":"1","preferredName":"Musculoskeletal Disease or Disorder","longName":"3158624","preferredDefinition":"Having to do with muscles, bones, and cartilage.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Musculoskeletal","conceptCode":"C25348","definition":"Pertaining to the muscles and skeleton.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94B8AE1D-5C41-C169-E040-BB89AD435EB4","latestVersionIndicator":"Yes","beginDate":"2010-11-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10159518-2A24-8BD2-E050-BB89AD43458A","beginDate":"2010-11-10","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-02-27","modifiedBy":"ONEDATA","dateModified":"2015-02-27","deletedIndicator":"No"},{"value":"Neurologic disease","valueDescription":"Neurologic Disease or Disorder","ValueMeaning":{"publicId":"3158623","version":"1","preferredName":"Neurologic Disease or Disorder","longName":"3158623","preferredDefinition":"(noor-uh-LOJ-ik) Having to do with nerves or the nervous system.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurologic","conceptCode":"C25262","definition":"Pertaining to nerves or the nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94B8AE1D-5C1E-C169-E040-BB89AD435EB4","latestVersionIndicator":"Yes","beginDate":"2010-11-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10159518-2A38-8BD2-E050-BB89AD43458A","beginDate":"2010-11-10","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-02-27","modifiedBy":"ONEDATA","dateModified":"2015-02-27","deletedIndicator":"No"},{"value":"Hematologic disease","valueDescription":"Hematologic Disease or Disorder","ValueMeaning":{"publicId":"5054451","version":"1","preferredName":"Hematologic Disease or Disorder","longName":"5054451","preferredDefinition":"Pertaining to or related to the blood and blood-forming organs.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25628B4B-6AEC-594C-E050-BB89AD430F0C","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25628B4B-6B05-594C-E050-BB89AD430F0C","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"ONEDATA","dateModified":"2015-11-25","deletedIndicator":"No"},{"value":"Solid tumor","valueDescription":"Solid Tumor","ValueMeaning":{"publicId":"4264994","version":"1","preferredName":"Solid Tumor","longName":"4264994","preferredDefinition":"An abnormal mass of tissue that usually does not contain cysts or liquid areas. Solid tumors may be benign (not cancer), or malignant (cancer). Different types of solid tumors are named for the type of cells that form them. Examples of solid tumors are sarcomas, carcinomas, and lymphomas. Leukemias (cancers of the blood) generally do not form solid tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3F94-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25628B4B-6B0F-594C-E050-BB89AD430F0C","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"ONEDATA","dateModified":"2015-11-25","deletedIndicator":"No"},{"value":"Pulmonary disease","valueDescription":"Lung Disorder","ValueMeaning":{"publicId":"5054452","version":"1","preferredName":"Lung Disorder","longName":"5054452","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Disorder","conceptCode":"C3198","definition":"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25628B4B-6B19-594C-E050-BB89AD430F0C","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25628B4B-6B32-594C-E050-BB89AD430F0C","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"ONEDATA","dateModified":"2015-11-25","deletedIndicator":"No"},{"value":"Ocular disease","valueDescription":"Ocular Disease or Disorder","ValueMeaning":{"publicId":"5054453","version":"1","preferredName":"Ocular Disease or Disorder","longName":"5054453","preferredDefinition":"Of or relating to the eye.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ocular","conceptCode":"C87163","definition":"Of or relating to the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25628B4B-6B3F-594C-E050-BB89AD430F0C","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25628B4B-6B58-594C-E050-BB89AD430F0C","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"ONEDATA","dateModified":"2015-11-25","deletedIndicator":"No"},{"value":"Other indication","valueDescription":"Other Indication","ValueMeaning":{"publicId":"3158657","version":"1","preferredName":"Other Indication","longName":"3158657","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94C8A52B-3A15-273E-E040-BB89AD435839","latestVersionIndicator":"Yes","beginDate":"2010-11-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-11-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25D8DB7A-9205-E85F-E050-BB89AD43339E","beginDate":"2015-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-01","modifiedBy":"ONEDATA","dateModified":"2015-12-01","deletedIndicator":"No"},{"value":"Suboptimal donor chimerism","valueDescription":"Suboptimal Donor Chimerism","ValueMeaning":{"publicId":"5062878","version":"1","preferredName":"Suboptimal Donor Chimerism","longName":"5062878","preferredDefinition":"Being below an optimal level or standard.: One that contributes something.: The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suboptimal","conceptCode":"C91065","definition":"Being below an optimal level or standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Donor","conceptCode":"C48284","definition":"One that contributes something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chimerism","conceptCode":"C62582","definition":"The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25D8DB7A-9213-E85F-E050-BB89AD43339E","latestVersionIndicator":"Yes","beginDate":"2015-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25D8DB7A-922C-E85F-E050-BB89AD43339E","beginDate":"2015-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-01","modifiedBy":"ONEDATA","dateModified":"2015-12-01","deletedIndicator":"No"},{"value":"Prevent disease relapse","valueDescription":"Recurrent Disease Preventive Intervention","ValueMeaning":{"publicId":"5062890","version":"1","preferredName":"Recurrent Disease Preventive Intervention","longName":"5062890","preferredDefinition":"The return of a disease after a period of remission.: In medicine, action taken to decrease the chance of getting a disease or condition. For example, cancer prevention includes avoiding risk factors (such as smoking, obesity, lack of exercise, and radiation exposure) and increasing protective factors (such as getting regular physical activity, staying at a healthy weight, and having a healthy diet).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25D995D3-3F0F-21A7-E050-BB89AD433FD0","latestVersionIndicator":"Yes","beginDate":"2015-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25D995D3-3F28-21A7-E050-BB89AD433FD0","beginDate":"2015-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-01","modifiedBy":"ONEDATA","dateModified":"2015-12-01","deletedIndicator":"No"},{"value":"GVHD prophylaxis","valueDescription":"Graft Versus Host Disease Preventive Intervention","ValueMeaning":{"publicId":"4987313","version":"1","preferredName":"Graft Versus Host Disease Preventive Intervention","longName":"4987313","preferredDefinition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.: In medicine, action taken to decrease the chance of getting a disease or condition. For example, cancer prevention includes avoiding risk factors (such as smoking, obesity, lack of exercise, and radiation exposure) and increasing protective factors (such as getting regular physical activity, staying at a healthy weight, and having a healthy diet).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E51253F-523F-36C4-E050-BB89AD434054","latestVersionIndicator":"Yes","beginDate":"2015-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25C6CC93-313D-9598-E050-BB89AD436A4D","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"ONEDATA","dateModified":"2015-11-30","deletedIndicator":"No"},{"value":"Immune reconstitution","valueDescription":"Immune Regeneration","ValueMeaning":{"publicId":"5056018","version":"1","preferredName":"Immune Regeneration","longName":"5056018","preferredDefinition":"Protected against infectious disease by either specific or non-specific mechanisms.: Reproduction or reconstitution of a lost or injured part. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune","conceptCode":"C17997","definition":"Protected against infectious disease by either specific or non-specific mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Regeneration","conceptCode":"C17083","definition":"Reproduction or reconstitution of a lost or injured part. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25C6CC93-314A-9598-E050-BB89AD436A4D","latestVersionIndicator":"Yes","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25C6CC93-3163-9598-E050-BB89AD436A4D","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"ONEDATA","dateModified":"2015-11-30","deletedIndicator":"No"},{"value":"Promote stem cell engraftment","valueDescription":"Promotion Progenitor Cell Engraftment","ValueMeaning":{"publicId":"5056019","version":"1","preferredName":"Promotion Progenitor Cell Engraftment","longName":"5056019","preferredDefinition":"Encouragement of the progress or growth or acceptance of something.: Establishment of a self replicating population of stem cells with subsequent repopulation of differentiated cell types.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Promotion","conceptCode":"C61391","definition":"Encouragement of the progress or growth or acceptance of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progenitor Cell Engraftment","conceptCode":"C16034","definition":"Establishment of a self replicating population of stem cells with subsequent repopulation of differentiated cell types.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25C6CC93-3170-9598-E050-BB89AD436A4D","latestVersionIndicator":"Yes","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25C6CC93-3189-9598-E050-BB89AD436A4D","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"ONEDATA","dateModified":"2015-11-30","deletedIndicator":"No"},{"value":"Induce immune tolerance","valueDescription":"Induction Immunologic Tolerance","ValueMeaning":{"publicId":"5056021","version":"1","preferredName":"Induction Immunologic Tolerance","longName":"5056021","preferredDefinition":"The act of bringing about something.: An innate tolerance that prevents the body from attacking native proteins and tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunologic Tolerance","conceptCode":"C17712","definition":"An innate tolerance that prevents the body from attacking native proteins and tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25C6CC93-3197-9598-E050-BB89AD436A4D","latestVersionIndicator":"Yes","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25C6CC93-31B0-9598-E050-BB89AD436A4D","beginDate":"2015-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-30","modifiedBy":"ONEDATA","dateModified":"2015-11-30","deletedIndicator":"No"},{"value":"Malignant hematologic disorder","valueDescription":"Malignant Hematologic Disease or Disorder","ValueMeaning":{"publicId":"5095312","version":"1","preferredName":"Malignant Hematologic Disease or Disorder","longName":"5095312","preferredDefinition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: Pertaining to or related to the blood and blood-forming organs.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant","conceptCode":"C14143","definition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28210682-A4CE-9240-E050-BB89AD430917","latestVersionIndicator":"Yes","beginDate":"2015-12-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28210682-A4E7-9240-E050-BB89AD430917","beginDate":"2015-12-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-30","modifiedBy":"ONEDATA","dateModified":"2015-12-30","deletedIndicator":"No"},{"value":"B cell lymphoproliferative disorder","valueDescription":"B-Lymphocyte Lymphoproliferative Disorder","ValueMeaning":{"publicId":"5085391","version":"1","preferredName":"B-Lymphocyte Lymphoproliferative Disorder","longName":"5085391","preferredDefinition":"Immunologically important lymphocyte that is not thymus-dependent, is either short-lived and naive or long-lived and of memory phenotype, and resembles the bursa-derived lymphocyte of birds in that it is responsible for the production of immunoglobulins.: A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Lymphocyte","conceptCode":"C12474","definition":"Immunologically important lymphocyte that is not thymus-dependent, is either short-lived and naive or long-lived and of memory phenotype, and resembles the bursa-derived lymphocyte of birds in that it is responsible for the production of immunoglobulins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphoproliferative Disorder","conceptCode":"C9308","definition":"A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27093AB0-E3CE-2338-E050-BB89AD430369","latestVersionIndicator":"Yes","beginDate":"2015-12-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27093AB0-E3E7-2338-E050-BB89AD430369","beginDate":"2015-12-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Relapsed, persistent or progressive disease","valueDescription":"Recurrent Disease Persistent Disease Or Progressive Disease","ValueMeaning":{"publicId":"5085392","version":"1","preferredName":"Recurrent Disease Persistent Disease Or Progressive Disease","longName":"5085392","preferredDefinition":"The return of a disease after a period of remission.: A disease that does not go to remission despite treatment.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Persistent Disease","conceptCode":"C90169","definition":"A disease that does not go to remission despite treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27093AB0-E3F6-2338-E050-BB89AD430369","latestVersionIndicator":"Yes","beginDate":"2015-12-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27093AB0-E40F-2338-E050-BB89AD430369","beginDate":"2015-12-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infectious Disorder","ValueMeaning":{"publicId":"4824551","version":"1","preferredName":"Infectious Disorder","longName":"4824551","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15F5F0DF-BD14-EF20-E050-BB89AD431CD6","latestVersionIndicator":"Yes","beginDate":"2015-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-05-13","modifiedBy":"KUMMEROA","dateModified":"2023-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27093AB0-E419-2338-E050-BB89AD430369","beginDate":"2015-12-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Cardiovascular disease","valueDescription":"Cardiovascular Disorder","ValueMeaning":{"publicId":"2630208","version":"1","preferredName":"Cardiovascular Disorder","longName":"2630208","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels).  Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension.  Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiovascular Disorder","conceptCode":"C2931","definition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E8C3390-BBE2-1B34-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-04-20","modifiedBy":"COLBERTM","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27093AB0-E423-2338-E050-BB89AD430369","beginDate":"2015-12-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"GVHD treatment","valueDescription":"Graft Versus Host Disease Therapeutic Procedure","ValueMeaning":{"publicId":"5062889","version":"1","preferredName":"Graft Versus Host Disease Therapeutic Procedure","longName":"5062889","preferredDefinition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25D995D3-3EE9-21A7-E050-BB89AD433FD0","latestVersionIndicator":"Yes","beginDate":"2015-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27093AB0-E437-2338-E050-BB89AD430369","beginDate":"2015-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Infection prophylaxis","valueDescription":"Infectious Disorder Preventive Intervention","ValueMeaning":{"publicId":"5280531","version":"1","preferredName":"Infectious Disorder Preventive Intervention","longName":"5280531","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.: In medicine, action taken to decrease the chance of getting a disease or condition. For example, cancer prevention includes avoiding risk factors (such as smoking, obesity, lack of exercise, and radiation exposure) and increasing protective factors (such as getting regular physical activity, staying at a healthy weight, and having a healthy diet).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33C2E438-CBDE-9E87-E050-BB89AD432524","latestVersionIndicator":"Yes","beginDate":"2016-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-05-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"33C2E438-CBF7-9E87-E050-BB89AD432524","beginDate":"2016-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-05-26","modifiedBy":"ONEDATA","dateModified":"2016-05-26","deletedIndicator":"No"},{"value":"Infection treatment","valueDescription":"Infectious Disorder Therapeutic Procedure","ValueMeaning":{"publicId":"5280532","version":"1","preferredName":"Infectious Disorder Therapeutic Procedure","longName":"5280532","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33C2E438-CC04-9E87-E050-BB89AD432524","latestVersionIndicator":"Yes","beginDate":"2016-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-05-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"33C2E438-CC1D-9E87-E050-BB89AD432524","beginDate":"2016-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-05-26","modifiedBy":"ONEDATA","dateModified":"2016-05-26","deletedIndicator":"No"},{"value":"Non-malignant disorder","valueDescription":"Negation Malignant Disease or Disorder","ValueMeaning":{"publicId":"5270111","version":"1","preferredName":"Negation Malignant Disease or Disorder","longName":"5270111","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant","conceptCode":"C14143","definition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"330EDF34-B290-21F6-E050-BB89AD430204","latestVersionIndicator":"Yes","beginDate":"2016-05-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"330EDF34-B2A9-21F6-E050-BB89AD430204","beginDate":"2016-05-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-05-17","modifiedBy":"ONEDATA","dateModified":"2016-05-17","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2572577","version":"1","preferredName":"Unknown","longName":"2572577","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E88E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-30","modifiedBy":"COLBERTM","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"50F9ABCE-AA5D-6C11-E053-F662850AB16B","beginDate":"2017-06-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-02","modifiedBy":"ONEDATA","dateModified":"2017-06-02","deletedIndicator":"No"},{"value":"Treatment of disease relapse/progression","valueDescription":"Disease Relapse/Progression Therapeutic Procedure","ValueMeaning":{"publicId":"8156347","version":"1","preferredName":"Disease Relapse/Progression Therapeutic Procedure","longName":"8156347","preferredDefinition":"Either the return of the disease or the progression of the disease.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Relapse/Progression","conceptCode":"C174991","definition":"Either the return of the disease or the progression of the disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC63F805-7ADF-4933-E053-4EBD850A6C33","latestVersionIndicator":"Yes","beginDate":"2022-04-11","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-11","modifiedBy":"ONEDATA","dateModified":"2022-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC63F805-7AF8-4933-E053-4EBD850A6C33","beginDate":"2022-04-11","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-11","modifiedBy":"ONEDATA","dateModified":"2022-04-11","deletedIndicator":"No"},{"value":"Treatment of MRD","valueDescription":null,"ValueMeaning":{"publicId":"10176509","version":"1","preferredName":"Minimal Residual Disease Therapeutic Procedure","longName":"10176509v1.00","preferredDefinition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DEAED41F-496A-5D71-E053-731AD00A2B4D","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-12","modifiedBy":"KUMMEROA","dateModified":"2022-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DEAED41F-496B-5D71-E053-731AD00A2B4D","beginDate":"2022-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-12","modifiedBy":"KUMMEROA","dateModified":"2022-05-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3158620","version":"1","preferredName":"Cellular Therapy Indication Reason","preferredDefinition":"Utilization of specific cells modified or not for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.:A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).:An explanation of the cause of some phenomenon or action.","longName":"C70601:C41184:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Therapy","conceptCode":"C70601","definition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94B8AE1D-5BD1-C169-E040-BB89AD435EB4","latestVersionIndicator":"Yes","beginDate":"2010-11-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-11-10","modifiedBy":"ONEDATA","dateModified":"2010-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A705C43-FB21-F5BD-E050-BB89AD432FFF","latestVersionIndicator":"Yes","beginDate":"2014-12-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-12-17","modifiedBy":"KUMMEROA","dateModified":"2022-05-12","changeDescription":". Added 4 PVs for 4000. AK 12/1/15 Added 2 PVs for 4000. AK 12/30/15 Added 2 PVs for 4000. AK 5/28/16 Added PV for 4000. AK 6/2/17. PV added for 2199. 04/11/2022 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CPRE_PCTM_primary_ct_indic_rsn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_PCTM_cell_thrpy_indicat","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_ICT_ct_indication","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_ICT_prim_cell_th_indic","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the primary indicatio","type":"Preferred Question Text","description":"What is the primary indication for cellular therapy?","url":null,"context":"NHLBI"},{"name":"Specify the primary indication for the prior cellular therapy","type":"Alternate Question Text","description":"Specify the primary indication for the prior cellular therapy","url":null,"context":"NHLBI"},{"name":"What was the primary indication for performing treatment with cellular therapy?","type":"Alternate Question Text","description":"What was the primary indication for performing treatment with cellular therapy?","url":null,"context":"NHLBI"},{"name":"Specify the primary indication for the prior cellular therapy","type":"Application Standard Question Text","description":"Specify the primary indication for the prior cellular therapy","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B295ADE8-FBF1-618E-E053-4EBD850AF303","latestVersionIndicator":"Yes","beginDate":"2020-10-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-26","modifiedBy":"MALUMK","dateModified":"2021-07-30","changeDescription":"Released. 01/28/2021 KMM; System generated def displayed as alt def. ALT name added for 4000r8. 07/30/2021. ALT name added for 4000r8. 07/30/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}